Ahmedabad, India

Nirav Vyas

This inventor holds 1 USPTO granted patent. Top assignee: Amneal Pharmaceuticals LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nirav Vyas. Retrieved from https://idiyas.com/inventor/nirav-vyas-urv0rqx9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nirav Vyas and His Pharmaceutical Invention.

Introduction

Nirav Vyas is an inventor associated with Ahmedabad, India, and Amneal Pharmaceuticals LLC. His patent work concerns the potential use of Levocloperastine in treating vertigo and related conditions.

Latest Patents

Vyas is named on one patent, titled “Anti-vertigo compound and pharmaceutical compositions thereof.” The invention describes using Levocloperastine to treat or prevent vertigo, diseases associated with vertigo, and related symptoms. It also covers oral pharmaceutical compositions containing Levocloperastine and one or more pharmaceutical excipients, along with a process for preparing those compositions. The supplied information lists 1 patent.

Career Highlights

The available information connects Vyas’s patent activity with pharmaceutical research and development at Amneal Pharmaceuticals LLC. His listed invention focuses on a therapeutic application and an oral formulation.

Collaborations

The patent’s pharmaceutical composition and preparation process reflect work within the broader context of pharmaceutical development. The supplied information does not identify additional collaborators.

Conclusion

Nirav Vyas’s listed patent addresses Levocloperastine-based approaches to vertigo treatment and oral pharmaceutical formulation, linking his inventive work with pharmaceutical development at Amneal Pharmaceuticals LLC.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…